The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives
Abstract
Nanotechnology is reshaping health care strategies and is expected to exert a tremendous impact in the coming years offering better healthcare facilities. It has led to not only therapeutic drug delivery feasibility but also to diagnostics. Materials in the size of nano range (1-100 mm) used in the design, fabrication, regulation, and application of therapeutic drugs or devices are classified as medical nanotechnology and nanopharmacology. Delivery of more complex molecules to the specific site of action as well as gene therapy has pushed forward the nanoparticle-based drug delivery to its maximum. Areas that benefit from nano-based drug delivery systems are cancer, diabetes, infectious diseases, neurodegenerative diseases, blood disorders and orthopedic-related ailments. Moreover, development of nanotherapeutics with multi-functionalities has a considerable potential to fill the gaps that exist in the present therapeutic domain. In cancer treatment, nanomedicines have superiority over current therapeutic practices as they can effectively deliver the drug to the affected tissues, thus reducing drug toxicities. Along this line, polymeric conjugates of asparaginase and polymeric micelles of paclitaxel have recently been recommended for the treatment of various types of cancers. Nanotechnology-based therapeutics and diagnostics provide greater effectiveness with less or no toxicity concerns. Similarly, diagnostic imaging holds promising future applications with newer nano-level imaging elements. Advancements in nanotechnology have emerged to a newer direction which use nanorobotics for various applications in healthcare. Accordingly, this review comprehensively highlights the potentialities of various nanocarriers and nanomedicines for multifaceted applications in diagnostics and drug delivery, especially the potentialities of polymeric nanoparticle, nanoemulsion, solid-lipid nanoparticle, nanostructured lipid carrier, self-micellizing anticancer lipids, dendrimer, nanocapsule and nanosponge-based therapeutic approaches in the field of cancer. Furthermore, this article summarizes the most recent literature pertaining to the use of nano-technology in the field of medicine, particularly in treating cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt920 · Cited by 2,087
Xia, T., Kovochich, M., Brant, J., Hotze, M., Sempf, J., Oberley, T., Sioutas, C., Yeh, J. I., Wiesner, M. R., & Nel, A. E. (2006) · Nano Letters · doi:10.1021/nl061025k · Cited by 1,918
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Biomedical Applications of Graphene and Graphene Oxide
Chung, C., Kim, Y.-K., Shin, D., Ryoo, S.-R., Hong, B. H., & Min, D.-H. (2013) · Accounts of Chemical Research · doi:10.1021/ar300159f · Cited by 1,696
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
The development of microgels/nanogels for drug delivery applications
Oh, J. K., Drumright, R., Siegwart, D. J., & Matyjaszewski, K. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2008.01.002 · Cited by 1,598
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
Hong, G., Diao, S., Antaris, A. L., & Dai, H. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00008 · Cited by 1,394
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities
Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900441 · Cited by 1,313
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Nanoemulsion: an advanced mode of drug delivery system
Jaiswal, M., Dudhe, R., & Sharma, P. K. (2015) · 3 Biotech · doi:10.1007/s13205-014-0214-0 · Cited by 1,203
Molecular targeted therapy: Treating cancer with specificity
Lee, Y. T., Tan, Y. J., & Oon, C. E. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.034 · Cited by 1,067
PI3K/AKT signaling pathway and cancer: An updated review
Martini, M., De Santis, M. C., Braccini, L., Gulluni, F., & Hirsch, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912836 · Cited by 1,020
Kobayashi, H., Watanabe, R., & Choyke, P. L. (2014) · Theranostics · doi:10.7150/thno.7193 · Cited by 996
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Assessment of the Evolution of Cancer Treatment Therapies
Arruebo, M., Vilaboa, N., Sáez-Gutierrez, B., Lambea, J., Tres, A., Valladares, M., & González-Fernández, Á. (2011) · Cancers · doi:10.3390/cancers3033279 · Cited by 931
Current Challenges in Cancer Treatment
Zugazagoitia, J., Guedes, C., Ponce, S., Ferrer, I., Molina-Pinelo, S., & Paz-Ares, L. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.026 · Cited by 926
Cancer nanomedicine: A review of recent success in drug delivery
Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879
Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials
Rolland, J. P., Maynor, B. W., Euliss, L. E., Exner, A. E., Denison, G. M., & DeSimone, J. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051977c · Cited by 852
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms
Ou, L., Song, B., Liang, H., Liu, J., Feng, X., Deng, B., Sun, T., & Shao, L. (2016) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0168-y · Cited by 803
Microenvironmental regulation of therapeutic response in cancer
Klemm, F., & Joyce, J. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 771
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Palmerston Mendes, L., Pan, J., & Torchilin, V. (2017) · Molecules · doi:10.3390/molecules22091401 · Cited by 701
Cancer nanomedicine: from targeted delivery to combination therapy
Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation
Soni, K. S., Desale, S. S., & Bronich, T. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.009 · Cited by 683
Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment
Fadeel, B., Bussy, C., Merino, S., Vázquez, E., Flahaut, E., Mouchet, F., Evariste, L., Gauthier, L., Koivisto, A. J., Vogel, U., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b04758 · Cited by 671
Polymer nanogels: A versatile nanoscopic drug delivery platform
Chacko, R. T., Ventura, J., Zhuang, J., & Thayumanavan, S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.002 · Cited by 645
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A., & Kzhyshkowska, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 628
Microvascular permeability of normal and neoplastic tissues
Gerlowski, L. E., & Jain, R. K. (1986) · Microvascular Research · doi:10.1016/0026-2862(86)90018-x · Cited by 622
Comparison Study of Gold Nanohexapods, Nanorods, and Nanocages for Photothermal Cancer Treatment
Wang, Y., Black, K. C. L., Luehmann, H., Li, W., Zhang, Y., Cai, X., Wan, D., Liu, S.-Y., Li, M., Kim, P., et al. (2013) · ACS Nano · doi:10.1021/nn304332s · Cited by 615
Atrp in the design of functional materials for biomedical applications
Siegwart, D. J., Oh, J. K., & Matyjaszewski, K. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.08.001 · Cited by 613
Dendritic polymer macromolecular carriers for drug delivery
Patri, A. K., Majoros, I. J., & Baker, J. R. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00347-2 · Cited by 595
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize
Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584
Translational Implications of Tumor Heterogeneity
Jamal-Hanjani, M., Quezada, S. A., Larkin, J., & Swanton, C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1429 · Cited by 549
Penetration of Intact Skin by Quantum Dots with Diverse Physicochemical Properties
Ryman-Rasmussen, J. P., Riviere, J. E., & Monteiro-Riviere, N. A. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj122 · Cited by 534
Nanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Microparticles and nanoparticles for drug delivery
Kohane, D. S. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21301 · Cited by 517
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jackson, J. R., Patrick, D. R., Dar, M. M., & Huang, P. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2049 · Cited by 473
Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells
Purwar, R., Schlapbach, C., Xiao, S., Kang, H. S., Elyaman, W., Jiang, X., Jetten, A. M., Khoury, S. J., Fuhlbrigge, R. C., Kuchroo, V. K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2856 · Cited by 442
Nanostructured lipid carriers system: Recent advances in drug delivery
Iqbal, M. A., Md, S., Sahni, J. K., Baboota, S., Dang, S., & Ali, J. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.716845 · Cited by 436
Cancer theranostics: the rise of targeted magnetic nanoparticles
Cole, A. J., Yang, V. C., & David, A. E. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.03.001 · Cited by 425
Regulatory aspects on nanomedicines
Sainz, V., Conniot, J., Matos, A. I., Peres, C., Zupanǒiǒ, E., Moura, L., Silva, L. C., Florindo, H. F., & Gaspar, R. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.023 · Cited by 417
Dasari Shareena, T. P., McShan, D., Dasmahapatra, A. K., & Tchounwou, P. B. (2018) · Nano-Micro Letters · doi:10.1007/s40820-018-0206-4 · Cited by 414
Theranostic applications of nanoparticles in cancer
Ahmed, N., Fessi, H., & Elaissari, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.010 · Cited by 409
Cancer drug delivery in the nano era: An overview and perspectives
Li, Z., Tan, S., Li, S., Shen, Q., & Wang, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5718 · Cited by 406
New approaches to molecular cancer therapeutics
Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 391
Inhibitors of cyclin-dependent kinases as cancer therapeutics.
Whittaker, S. R., Mallinger, A., Workman, P., & Clarke, P. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.008 · Cited by 384
Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting
Fang, C.-L., A. Al-Suwayeh, S., & Fang, J.-Y. (2013) · Recent Patents on Nanotechnology · doi:10.2174/187221013804484827 · Cited by 367
Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
Zhang, Z., Tsai, P., Ramezanli, T., & Michniak‐Kohn, B. B. (2013) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1211 · Cited by 357
Chen, F., Hong, H., Zhang, Y., Valdovinos, H. F., Shi, S., Kwon, G. S., Theuer, C. P., Barnhart, T. E., & Cai, W. (2013) · ACS Nano · doi:10.1021/nn403617j · Cited by 346
Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody
Wang, C., Sun, W., Wright, G., Wang, A. Z., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201506312 · Cited by 344
Hingorani, S. R., Harris, W. P., Beck, J. T., Berdov, B. A., Wagner, S. A., Pshevlotsky, E. M., Tjulandin, S. A., Gladkov, O. A., Holcombe, R. F., Korn, R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2010 · Cited by 333
Lipoprotein-Inspired Nanoparticles for Cancer Theranostics
Ng, K. K., Lovell, J. F., & Zheng, G. (2011) · Accounts of Chemical Research · doi:10.1021/ar200017e · Cited by 330
Wang, J., Tian, S., Petros, R. A., Napier, M. E., & DeSimone, J. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1043177 · Cited by 330
Cocoon-Like Self-Degradable DNA Nanoclew for Anticancer Drug Delivery
Sun, W., Jiang, T., Lu, Y., Reiff, M., Mo, R., & Gu, Z. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5088024 · Cited by 329
Chen, F., Ehlerding, E. B., & Cai, W. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.146019 · Cited by 328
Towards clinically translatable in vivo nanodiagnostics
Park, S.-M., Aalipour, A., Vermesh, O., Yu, J. H., & Gambhir, S. S. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.14 · Cited by 327
Prasad, M., Lambe, U. P., Brar, B., Shah, I., J, M., Ranjan, K., Rao, R., Kumar, S., Mahant, S., Khurana, S. K., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.026 · Cited by 327
Lee, G. Y., Qian, W. P., Wang, L., Wang, Y. A., Staley, C. A., Satpathy, M., Nie, S., Mao, H., & Yang, L. (2013) · ACS Nano · doi:10.1021/nn3043463 · Cited by 324
Biomarker-guided therapy for colorectal cancer: strength in complexity
Sveen, A., Kopetz, S., & Lothe, R. A. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0241-1 · Cited by 320
Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer
Shannan, B., Seifert, M., Leskov, K., Willis, J., Boothman, D., Tilgen, W., & Reichrath, J. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401779 · Cited by 318
Blood Brain Barrier: A Challenge for Effectual Therapy of Brain Tumors
Bhowmik, A., Khan, R., & Ghosh, M. K. (2015) · BioMed Research International · doi:10.1155/2015/320941 · Cited by 291
Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
Villa, E., Ali, E., Sahu, U., & Ben-Sahra, I. (2019) · Cancers · doi:10.3390/cancers11050688 · Cited by 281
Self-citationPotential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
Baig, S., Seevasant, I., Mohamad, J., Mukheem, A., Huri, H. Z., & Kamarul, T. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.275 · Cited by 279
Current Applications of Nanoemulsions in Cancer Therapeutics
Sánchez-López, E., Guerra, M., Dias-Ferreira, J., Lopez-Machado, A., Ettcheto, M., Cano, A., Espina, M., Camins, A., Garcia, M. L., & Souto, E. B. (2019) · Nanomaterials · doi:10.3390/nano9060821 · Cited by 276
McAllister, K., Sazani, P., Adam, M., Cho, M. J., Rubinstein, M., Samulski, R. J., & DeSimone, J. M. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027759q · Cited by 273
Cancer biomarkers: knowing the present and predicting the future
Chatterjee, S. K., & Zetter, B. R. (2005) · Future Oncology · doi:10.1517/14796694.1.1.37 · Cited by 269
Safety assessment of nanomaterials: Implications for nanomedicine
Nyström, A. M., & Fadeel, B. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.027 · Cited by 264
Biophysical Regulation of Cell Behavior—Cross Talk between Substrate Stiffness and Nanotopography
Yang, Y., Wang, K., Gu, X., & Leong, K. W. (2017) · Engineering · doi:10.1016/j.eng.2017.01.014 · Cited by 263
Carbon‐Based Nanomaterials for Cancer Therapy via Targeting Tumor Microenvironment
Saleem, J., Wang, L., & Chen, C. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800525 · Cited by 262
Preparation of solid lipid nanoparticles using a membrane contactor
Charcosset, C., El-Harati, A., & Fessi, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.023 · Cited by 250
Iwamoto, T. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-01102 · Cited by 247
Tumor-targeted nanomedicines for cancer theranostics
Arranja, A. G., Pathak, V., Lammers, T., & Shi, Y. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.014 · Cited by 246
Cooperative Nanoparticles for Tumor Detection and Photothermally Triggered Drug Delivery
Park, J., von Maltzahn, G., Ong, L. L., Centrone, A., Hatton, T. A., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Advanced Materials · doi:10.1002/adma.200902895 · Cited by 238
Vallhov, H., Qin, J., Johansson, S. M., Ahlborg, N., Muhammed, M. A., Scheynius, A., & Gabrielsson, S. (2006) · Nano Letters · doi:10.1021/nl060860z · Cited by 238
Self‐Assembled Smart Nanocarriers for Targeted Drug Delivery
Cui, W., Li, J., & Decher, G. (2016) · Advanced Materials · doi:10.1002/adma.201502479 · Cited by 235
Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Perche, F., & Torchilin, V. P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/705265 · Cited by 230
Fan, Z., Shelton, M., Singh, A. K., Senapati, D., Khan, S. A., & Ray, P. C. (2012) · ACS Nano · doi:10.1021/nn2045246 · Cited by 228
Yoon, G., Park, J. W., & Yoon, I.-S. (2013) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-013-0087-y · Cited by 224
Nanotheranostics for personalized medicine
Kim, T. H., Lee, S., & Chen, X. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.13.15 · Cited by 222
Lundberg, L. G., Lerner, R., Sundelin, P., Rogers, R., Folkman, J., & Palmblad, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64511-7 · Cited by 219
Gao, F., Zhang, Z., Bu, H., Huang, Y., Gao, Z., Shen, J., Zhao, C., & Li, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.013 · Cited by 219
Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy
Jo, S. D., Ku, S. H., Won, Y.-Y., Kim, S. H., & Kwon, I. C. (2016) · Theranostics · doi:10.7150/thno.15335 · Cited by 218
Mashaghi, S., Jadidi, T., Koenderink, G., & Mashaghi, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14024242 · Cited by 210
Nanoscience, nanotoxicology, and the need to think small
Seaton, A., & Donaldson, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71061-8 · Cited by 207
Zhang, D.-Y., Zheng, Y., Tan, C.-P., Sun, J.-H., Zhang, W., Ji, L.-N., & Mao, Z.-W. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b13808 · Cited by 192
Ganesan, P., Ramalingam, P., Karthivashan, G., Ko, Y. T., & Choi, D.-K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s155593 · Cited by 184
Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies
Ediriwickrema, A., & Saltzman, W. M. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/ab500084g · Cited by 183
Nanocapsules: The Weapons for Novel Drug Delivery Systems
Kothamasu, P., Kanumur, H., Ravur, N., Maddu, C., Parasuramrajam, R., & Thangavel, S. (2012) · Europe PMC (PubMed Central) · doi:10.5681/bi.2012.011 · Cited by 172
RAFT/MADIX polymers for the preparation of polymer/inorganic nanohybrids
Beija, M., Marty, J.-D., & Destarac, M. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.002 · Cited by 171
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Benny, O., Fainaru, O., Adini, A., Cassiola, F., Bazinet, L., Adini, I., Pravda, E., Nahmias, Y., Koirala, S., Corfas, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1415 · Cited by 171
Nanoparticle-siRNA: A potential cancer therapy?
Young, S. W. S., Stenzel, M., & Jia-Lin, Y. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.015 · Cited by 161
Theranostic nanomedicine for cancer detection and treatment
Fan, Z., Fu, P. P., Yu, H., & Ray, P. C. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.001 · Cited by 160
Sharker, S. M., Lee, J. E., Kim, S. H., Jeong, J. H., In, I., Lee, H., & Park, S. Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.040 · Cited by 158
Self-citationDoherty, G. J., Tempero, M. A., & Corrie, P. G. (2017) · Future Oncology · doi:10.2217/fon-2017-0338 · Cited by 158
Multifunctional nanoparticles: recent progress in cancer therapeutics
Raju, G. S. R., Benton, L., Pavitra, E., & Yu, J. S. (2015) · Chemical Communications · doi:10.1039/c5cc04643b · Cited by 157
Nanostructures in Drug Delivery
Tammam, S. N., & Lamprecht, A. (2016) · Wiley eBooks · doi:10.1002/9783527800681.ch6 · Cited by 155
Molecular Diagnostics in Clinical Oncology
Соколенко, А. П., & Имянитов, Е. Н. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00076 · Cited by 154
Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens
Crawford, E. D., Schellhammer, P. F., McLeod, D. G., Moul, J. W., Higano, C. S., Shore, N. D., Denis, L., Iversen, P., Eisenberger, M. A., & Labrie, F. (2018) · The Journal of Urology · doi:10.1016/j.juro.2018.04.083 · Cited by 153
Zhang, M., Wang, W., Wu, F., Yuan, P., Chi, C., & Zhou, N. (2017) · Carbon · doi:10.1016/j.carbon.2017.07.032 · Cited by 151
Kolesnick, R. N., Haimovitz‐Friedman, A., & FUKS, Z. Y. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-063 · Cited by 149
Dragovich, T., Mendelson, D. S., Kurtin, S. E., Richardson, K., Hoff, D. D. V., & Hoos, A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0235-4 · Cited by 142
Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
Harb, J. F., Lin, P.-J., & Hao, J. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0763-9 · Cited by 141
Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer
Mukherjee, A., Paul, M. K., & Mukherjee, S. (2019) · Cancers · doi:10.3390/cancers11050597 · Cited by 138
Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy
Gkretsi, V., Stylianou, A., Papageorgis, P., Polydorou, C., & Stylianopoulos, T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00214 · Cited by 134
Nanotopography promoted neuronal differentiation of human induced pluripotent stem cells
Song, L., Wang, K., Li, Y., & Yang, Y. S. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.041 · Cited by 128
Graphene-Based Nanomaterials for Nanobiotechnology and Biomedical Applications
Krishna, K. V., Ménard‐Moyon, C., Verma, S. K., & Bianco, A. (2013) · Nanomedicine · doi:10.2217/nnm.13.140 · Cited by 127
Kanapathipillai, M., Mammoto, A., Mammoto, T., Kang, J. H., Jiang, E., Ghosh, K., Korin, N., Gibbs, A. D., Mannix, R. J., & Ingber, D. E. (2012) · Nano Letters · doi:10.1021/nl301206p · Cited by 125
Combustion-Derived Ultrafine Particles Transport Organic Toxicants to Target Respiratory Cells
Penn, A. L., Murphy, G., Barker, S. A., Henk, W. G., & Penn, L. S. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7661 · Cited by 120
Rishitha, N., & Muthuraman, A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.010 · Cited by 120
Modulation of the Tumor Microenvironment for Cancer Treatment: A Biomaterials Approach
Adjei, I. M., & Sharma, B. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6010081 · Cited by 117
Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management
Koo, K. M., Mainwaring, P. N., Tomlins, S. A., & Trau, M. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0178-2 · Cited by 115
Molecular Targeted Therapy of Lung Cancer: EGFR Mutations and Response to EGFR InhibitorsPreprint
Haber, D. A., Bell, D. W., Sordella, R., Kwak, E. L., Godin-Heymann, N., Sharma, S. V., Lynch, T. J., & Settleman, J. E. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.043 · Cited by 114
Nanotechnology-mediated targeting of tumor angiogenesis
Banerjee, D., Harfouche, R., & Sengupta, S. (2011) · Vascular Cell · doi:10.1186/2045-824x-3-3 · Cited by 108
PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy
Chen, Z., Penet, M., Nimmagadda, S., Li, C., Banerjee, S. R., Winnard, P. T., Artemov, D., Glunde, K., Pomper, M. G., & Bhujwalla, Z. M. (2012) · ACS Nano · doi:10.1021/nn301725w · Cited by 107
Sharker, S. M., Kim, S. M., Lee, J. E., Choi, K. H., Shin, G., Lee, S., Lee, K. D., Jeong, J. H., Lee, H., & Park, S. Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.010 · Cited by 105
Self-citationNanomedicines for advanced cancer treatments: Transitioning towards responsive systems
van Elk, M., Murphy, B. P., Eufrásio-da-Silva, T., O’Reilly, D. P., Vermonden, T., Hennink, W. E., Duffy, G. P., & Ruiz‐Hernández, E. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.013 · Cited by 104
Drug delivery: advancements and challenges
Singh, N., Joshi, A., Toor, A. P., & Verma, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00027-0 · Cited by 104
Targeting the Androgen Receptor in Breast Cancer
Chia, K., O’Brien, M., Brown, M. A., & Lim, E. (2015) · Current Oncology Reports · doi:10.1007/s11912-014-0427-8 · Cited by 103
Hyun, K.-A., Lee, T. Y., & Jung, H.-I. (2013) · Analytical Chemistry · doi:10.1021/ac3037766 · Cited by 102
Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles
Zhang, B., Shen, S., Liao, Z., Shi, W., Wang, Y., Zhao, J., Hu, Y., Yang, J., Chen, J., Mei, H., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.046 · Cited by 102
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
Pavitra, E., Dariya, B., Srivani, G., Kang, S.-M., Alam, A., Sudhir, P.-R., Kamal, M. A., Raju, G. S. R., Han, Y.-K., Lakkakula, B. V. K. S., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.017 · Cited by 102
Drug targeting systems for inflammatory disease: One for all, all for one
Crielaard, B. J., Lammers, T., Schiffelers, R. M., & Storm, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.014 · Cited by 101
Ma, Y., Cai, F., Li, Y., Chen, J., Han, F., & Lin, W. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.05.002 · Cited by 91
An innovative MWCNTs/DOX/TC nanosystem for chemo-photothermal combination therapy of cancer
Dong, X., Sun, Z., Wang, X., & Leng, X. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.07.002 · Cited by 89
pH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapy
Ramasamy, T., Kim, J. H., Kim, J. H., et al. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00867g · Cited by 88
Yang, D. C., Wang, F., Elliott, R. L., & Head, J. F. (2001) · PubMed · Cited by 87
Sundaramoorthy, P., Ramasamy, T., Mishra, S. K., Jeong, K., Yong, C. S., Kim, J. O., & Kim, H. M. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.07.006 · Cited by 86
Self-citationTargeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
Wilkes, G. M. (2018) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/apjon.apjon_79_17 · Cited by 85
Cesca, M., Bizzaro, F., Zucchetti, M., & Giavazzi, R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00259 · Cited by 84
Investigation of Cellular and Molecular Responses to Pulsed Focused Ultrasound in a Mouse Model
Burks, S. R., Ziadloo, A., Hancock, H. A., Chaudhry, A., Dean, D. D., Lewis, B. K., Frenkel, V., & Frank, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024730 · Cited by 77
Nanocarriers in cancer clinical practice: a pharmacokinetic issue
Giodini, L., Re, F. L., Campagnol, D., Marangon, E., Posocco, B., Dreussi, E., & Toffoli, G. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.07.012 · Cited by 77
Effect of Aspect Ratio and Deformability on Nanoparticle Extravasation through Nanopores
Kersey, F. R., Merkel, T. J., Perry, J. L., Napier, M. E., & DeSimone, J. M. (2012) · Langmuir · doi:10.1021/la301279v · Cited by 76
PEGylated anticancer-carbon nanotubes complex targeting mitochondria of lung cancer cells
Kim, S., Lee, Y. K., Lee, J. Y., Hong, J. H., & Khang, D. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa8c31 · Cited by 76
Kostadinova, I. (2014) · Journal of Nuclear Medicine · Cited by 74
Recombinant human transferrin: Beyond iron binding and transport
Brandsma, M. E., Jevnikar, A. M., & Ma, S. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.11.007 · Cited by 69
Martín‐Saldaña, S., Palao‐Suay, R., Aguilar, M. R., Ramírez‐Camacho, R., & Román, J. S. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.02.019 · Cited by 68
Siegler, E. L., Kim, Y. J., & Wang, P. (2016) · Journal of Cellular Immunotherapy · doi:10.1016/j.jocit.2016.08.002 · Cited by 65
Ali, E. S., Jin, H., Wilson, C. H., Tallis, G. A., Zhou, F. H., Rychkov, G. Y., & Barritt, G. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.05.006 · Cited by 61
Self-citationAn overview on the current status of cancer nanomedicines
Jabir, N. R., Anwar, K., Firoz, C. K., Oves, M., Kamal, M. A., & Tabrez, S. S. M. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1421528 · Cited by 61
Ali, E. S., Rychkov, G. Y., & Barritt, G. J. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.102057 · Cited by 61
Self-citationPeetla, C., Jin, S.-H., Weimer, J. M., Elegbede, A. I., & Labhasetwar, V. D. (2014) · Langmuir · doi:10.1021/la5015219 · Cited by 59
Sustainable Delivery Systems Through Green Nanotechnology
Krishnaswamy, K., & Orsat, V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52727-9.00002-9 · Cited by 59
Spaans, J. N., & Goss, G. D. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00190 · Cited by 57
Su, Y., Hu, Y., Wang, Y., Xu, X., Yuan, Y., Li, Y., Wang, Z., Chen, K., Zhang, F., Ding, X., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.046 · Cited by 57
Winn, R. A., Sechler, Cizmic, Avasarala, Scoyk, V., Brzezinski, Bikkavilli, & Kelley (2013) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s26058 · Cited by 56
Linton, S. S., Sherwood, S. G., Drews, K. C., & KESTER, M. A. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1358 · Cited by 56
Folate-targeted immunotherapies: Passive and active strategies for cancer
Farran, B., Pavitra, E., Kasa, P., Peela, S., Raju, G. S. R., & Nagaraju, G. P. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.02.001 · Cited by 55
Calcium Signaling As a Therapeutic Target for Liver Steatosis
Ali, E. S., & Petrovsky, N. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.02.005 · Cited by 50
Self-citationBouclier, C., Moine, L., Hillaireau, H., Marsaud, V., Connault, E., Opolon, P., Couvreur, P., Fattal, E., & Renoir, J. (2008) · Biomacromolecules · doi:10.1021/bm800664c · Cited by 49
Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
Balasubramanian, V., Liu, Z., Hirvonen, J. J., & Santos, H. A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700432 · Cited by 49
Tynga, I. M., & Abrahamse, H. (2018) · Nanomaterials · doi:10.3390/nano8110923 · Cited by 48
Horizons of nanotechnology applications in female specific cancers
Rajitha, B., Malla, R. R., Vadde, R., Kasa, P., Prasad, G. L. V., Farran, B., Kumari, S., Pavitra, E., Kamal, M. A., Raju, G. S. R., et al. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.005 · Cited by 47
Wu, H., Zhao, Y., Mu, X., Wu, H., Chen, L., Liu, W., Mu, Y., Liu, J., & Wei, X. (2015) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2015.1012035 · Cited by 45
Nanomaterials multifunctional behavior for enlightened cancer therapeutics
Raju, G. S. R., Dariya, B., Mungamuri, S. K., Chalikonda, G., Kang, S., Khan, I. N., Sushma, P. S., Nagaraju, G. P., Pavitra, E., & Han, Y. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.013 · Cited by 45
Self-citationHoy, S. M. (2014) · Drugs · doi:10.1007/s40265-014-0291-8 · Cited by 44
Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging
Schiepers, C. W., & Dahlbom, M. L. (2010) · European Radiology · doi:10.1007/s00330-010-2033-y · Cited by 41
Solid lipid nanoparticles in cancer therapy.
Mathur, V., Satrawala, Y., Rajput, M. S., Kumar, P., Shrivastava, P., & Vishvkarma, A. (2010) · International Journal of Drug Delivery · doi:10.5138/ijdd.2010.0975.0215.02029 · Cited by 40
Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization
Ramasamy, T., Choi, J. Y., Cho, H. J., Umadevi, K., Shin, B. S., Choi, H., Yong, C. S., & Kim, J. O. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1588-8 · Cited by 40
Developments in the use of nanocapsules in oncology
Yurgel, V. C., Collares, T. V., & Seixas, F. K. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132643 · Cited by 37
Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers
Leng, F., Liu, F., Yang, Y., Wu, Y., & Tian, W. (2018) · Nanomaterials · doi:10.3390/nano8040202 · Cited by 37
Feng, M., Lx, Z., Zy, Z., Zh, H., & Jp, X. (2017) · PubMed · Cited by 36
Simion, V., Constantinescu, C. A., Stan, D. L., Deleanu, M., Tucureanu, M. M., Butoi, E. D., Mânduțeanu, I., Simionescu, M., & Călin, M. (2016) · Mediators of Inflammation · doi:10.1155/2016/1625149 · Cited by 33
Overview of Cell Signaling Pathways in Cancer
Harvey, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-95228-4_12 · Cited by 32
Drug-induced amplification of nanoparticle targeting to tumors
Lin, K., Kwon, E. J., Lo, J. H.-J., & Bhatia, S. N. (2014) · Nano Today · doi:10.1016/j.nantod.2014.09.001 · Cited by 30
Ali, E. S., Rychkov, G. Y., & Barritt, G. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57732-6_30 · Cited by 29
Self-citationCarbon nanotubes induced fibrogenesis on nanostructured substrates
Wang, K., He, X., Linthicum, W., Mezan, R., Wang, L., Rojanasakul, Y., Wen, Q., & Yang, Y. S. (2017) · Environmental Science Nano · doi:10.1039/c6en00402d · Cited by 26
Basic Concepts of Molecular Pathology
Allen, T. C., Cagle, P. T., & Popper, H. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2008-132-1551-bcomp · Cited by 25
Pavitra, E., Raju, G. S. R., Nagaraju, G. P., Nagaraju, G., Han, Y., Huh, Y. S., & Yu, J. S. (2017) · Chemical Communications · doi:10.1039/c7cc07975c · Cited by 20
Dai, Y., Huang, J., Xiang, B., Zhu, H., & He, C. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2688-x · Cited by 20
Novel self-micellizing anticancer lipid nanoparticles induce cell death of colorectal cancer cells
Sundaramoorthy, P., Baskaran, R., Mishra, S. K., et al. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.08.039 · Cited by 18
Self-citationMolecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy
Copur, M. S., Crockett, D., Gauchan, D., Ramaekers, R. C., & Mleczko, K. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8240 · Cited by 16
Critical Analysis of Cancer Therapy using Nanomaterials
Juillerat‐Jeanneret, L. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0066 · Cited by 14
Karpathiou, G., Batistatou, A. K., Forest, F., Clémenson, A., & Péoc’h, M. (2016) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000124 · Cited by 11
Cited by
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Yue, N.-N., Xu, H.-M., Xu, J., Zhu, M.-Z., Zhang, Y., Tian, C.-M., Nie, Y.-Q., Yao, J., Liang, Y.-J., Li, D.-F., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s413141 · Cited by 46
Guo, X., Han, L., Chen, W., He, H., Zhang, W., Huang, C., & Wang, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s432407 · Cited by 14
Metadata
- Authors
- Ali, E. S., Sharker, S. M., Islam, M. T., Khan, I. N., Shaw, S., Rahman, M. A., Uddin, S. J., Shill, M. C., Rehman, S., Das, N., Ahmad, S., Shilpi, J. A., Tripathi, S., Mishra, S. K., & Mubarak, M. S.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 69
- Pages
- 52-68
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W3003452994
- Cited by
- 267
- References
- 201
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.